Athanase Innovation AB (ATIN) - Total Liabilities

Latest as of June 2026: Skr66.61 Million SEK ≈ $7.17 Million USD

Based on the latest financial reports, Athanase Innovation AB (ATIN) has total liabilities worth Skr66.61 Million SEK (≈ $7.17 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Athanase Innovation AB asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Athanase Innovation AB - Total Liabilities Trend (2017–2026)

This chart illustrates how Athanase Innovation AB's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see ATIN current and non-current assets.

Athanase Innovation AB Competitors by Total Liabilities

The table below lists competitors of Athanase Innovation AB ranked by their total liabilities.

Company	Country	Total Liabilities
Energia Latina SA SN:ENLASA	Chile	CL$56.58 Million
Gihon Telekomunikasi Indonesia Tbk PT JK:GHON	Indonesia	Rp586.75 Billion
Daehan New Pharm Co. Ltd KQ:054670	Korea	₩122.10 Billion
Sachem Capital Corp NYSE MKT:SACH	USA	$285.11 Million
International Conveyors Limited NSE:INTLCONV	India	Rs1.44 Billion
Hansol Csn KO:009180	Korea	₩123.82 Billion
Somnomed Ltd AU:SOM	Australia	AU$29.86 Million
Acrivon Therapeutics, Inc. Common Stock NASDAQ:ACRV	USA	$16.70 Million

Liability Composition Analysis (2017–2026)

This chart breaks down Athanase Innovation AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Athanase Innovation AB balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	N/A	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.16	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.14	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Athanase Innovation AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Athanase Innovation AB (2017–2026)

The table below shows the annual total liabilities of Athanase Innovation AB from 2017 to 2026.

Year	Total Liabilities	Change
2026-06-30	Skr53.90 Million ≈ $5.80 Million	-19.80%
2025-06-30	Skr67.20 Million ≈ $7.23 Million	+36.89%
2024-06-30	Skr49.09 Million ≈ $5.28 Million	+38.85%
2023-06-30	Skr35.36 Million ≈ $3.81 Million	+212.91%
2022-06-30	Skr11.30 Million ≈ $1.22 Million	+7693.10%
2021-06-30	Skr145.00K ≈ $15.60K	-99.97%
2020-06-30	Skr432.85 Million ≈ $46.58 Million	-0.36%
2019-06-30	Skr434.40 Million ≈ $46.75 Million	-0.01%
2018-06-30	Skr434.42 Million ≈ $46.75 Million	-39.15%
2017-06-30	Skr713.87 Million ≈ $76.82 Million	--

About Athanase Innovation AB

ST:ATIN Sweden Asset Management

Market Cap

$52.76 Million

Skr490.27 Million SEK

Market Cap Rank

#21788 Global

#397 in Sweden

Share Price

Skr20.20

Change (1 day)

-0.98%

52-Week Range

Skr12.00 - Skr21.60

All Time High

Skr2115.29